JFL Life

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE0LA901015
  • NSEID: JFLLIFE
  • BSEID:
INR
9.90
-0.45 (-4.35%)
BSENSE

Sep 29, 10:48 AM

BSE+NSE Vol: 30000

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
JFL Life
Roopa Industries
Guj. Terce Labs.
Sandu Pharma.
Vivo Bio Tech
Lasa Supergeneri
Welcure Drugs
Medi Caps
Medicamen Organ.
Goldline Pharmac
Chandra Bhagat

Why is JFL Life Sciences Ltd ?

1
Company has a Debt to Equity ratio (avg) of 0.35 times
2
Healthy long term growth as Net Sales has grown by an annual rate of 32.00% and Operating profit at 41.41%
  • NET SALES(Latest six months) At Rs 74.15 cr has Grown at 217.97%
  • PAT(Latest six months) At Rs 2.77 cr has Grown at 233.73%
3
With ROCE of 16.1, it has a Very Attractive valuation with a 0.8 Enterprise value to Capital Employed
  • Over the past year, while the stock has generated a return of -100.00%, its profits have risen by 54% ; the PEG ratio of the company is 0.1
4
Majority shareholders : Promoters
5
Below par performance in long term as well as near term
  • Along with generating -100.00% returns in the last 1 year, the stock has also underperformed BSE500 in the last 3 years, 1 year and 3 months
stock-recommendationReal-Time Research Report

Verdict Report

How much should you hold?

  1. Overall Portfolio exposure to JFL Life should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is JFL Life for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
JFL Life
-22.05%
-0.42
52.53%
Sensex
-9.61%
-0.71
13.67%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
32.00%
EBIT Growth (5y)
41.41%
EBIT to Interest (avg)
5.41
Debt to EBITDA (avg)
1.44
Net Debt to Equity (avg)
0.44
Sales to Capital Employed (avg)
1.56
Tax Ratio
21.91%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
13.67%
ROE (avg)
12.27%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
5
Industry P/E
Price to Book Value
0.74
EV to EBIT
5.07
EV to EBITDA
4.58
EV to Capital Employed
0.82
EV to Sales
0.42
PEG Ratio
0.09
Dividend Yield
NA
ROCE (Latest)
16.09%
ROE (Latest)
14.74%
Loading Valuation Snapshot...
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Bullish
Bearish
Dow Theory
No Trend
Mildly Bullish
OBV
No Trend
Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

18What is working for the Company
NET SALES(Latest six months)

At Rs 74.15 cr has Grown at 217.97%

PAT(Latest six months)

At Rs 2.77 cr has Grown at 233.73%

-4What is not working for the Company
NET SALES(Q)

Lowest at Rs 11.10 cr

Loading Valuation Snapshot...

Here's what is working for JFL Life

Profit After Tax (PAT) - Latest six months
At Rs 2.77 cr has Grown at 233.73%
Year on Year (YoY)
MOJO Watch
PAT trend is very positive

PAT (Rs Cr)

Here's what is not working for JFL Life

Net Sales - Quarterly
At Rs 11.10 cr has Fallen at -66.2% (vs previous 4Q average)
over average Net Sales of the previous four quarters of Rs 32.85 Cr
MOJO Watch
Near term sales trend is very negative

Net Sales (Rs Cr)

Net Sales - Quarterly
Lowest at Rs 11.10 cr
in the last five quarters
MOJO Watch
Near term sales trend is negative

Net Sales (Rs Cr)

Footer loading